临床癌症研究 - 爱唯医学网

Highlights of This Issue
Clin Cancer Res January 1, 2013 19:1
- Full Text
- Full Text (PDF)
- Request Permissions

CCR Translations

Select this article
Secrets of Drug Resistance in NSCLC Exposed by New Molecular Definition of EMT
- Dana S. Neel and
- Trever G. Bivona
Clin Cancer Res January 1, 2013 19:3-5; Published OnlineFirst November 21, 2012;doi:10.1158/1078-0432.CCR-12-3232
- Abstract
- Full Text
- Full Text (PDF)
- Figures Only
- Request Permissions

CCR Perspectives in Drug Approval

Select this article
Technology Assessment for New Oncology Drugs
- Bengt Jönsson
Clin Cancer Res January 1, 2013 19:6-11; doi:10.1158/1078-0432.CCR-12-1819
- Abstract
- Full Text
- Full Text (PDF)
- Figures Only
- Request Permissions

Statistics in Clinical Cancer Research

Select this article
Competing Risks and Multistate Models
- Claudia Schmoor,
- Martin Schumacher,
- Jürgen Finke,
- and Jan Beyersmann
Clin Cancer Res January 1, 2013 19:12-21; Published OnlineFirst November 21, 2012; doi:10.1158/1078-0432.CCR-12-1619
- Abstract
- Full Text
- Full Text (PDF)
- Figures Only
- Supplementary Data
- Request Permissions

CCR Drug Updates

Select this article
Brentuximab Vedotin
- Changchun Deng,
- Beiqing Pan,
- and Owen A. O'Connor
Clin Cancer Res January 1, 2013 19:22-27; Published OnlineFirst November 15, 2012; doi:10.1158/1078-0432.CCR-12-0290
- Abstract
- Full Text
- Full Text (PDF)
- Figures Only
- Request Permissions

Molecular Pathways

Select this article
Molecular Pathways: Involvement of Immune Pathways in the Therapeutic Response and Outcome in Breast Cancer
- Fabrice Andre,
- Maria V. Dieci,
- Peter Dubsky,
- Christos Sotiriou,
- Giuseppe Curigliano,
- Carsten Denkert,
- and Sherene Loi
Clin Cancer Res January 1, 2013 19:28-33; Published OnlineFirst December 20, 2012; doi:10.1158/1078-0432.CCR-11-2701
- Abstract
- Full Text
- Full Text (PDF)
- Figures Only
- Request Permissions
Select this article
Molecular Pathways: Targeting Mdm2 and Mdm4 in Cancer Therapy
- Qin Li and
- Guillermina Lozano
Clin Cancer Res January 1, 2013 19:34-41; Published OnlineFirst December 21, 2012; doi:10.1158/1078-0432.CCR-12-0053
- Abstract
- Full Text
- Full Text (PDF)
- Figures Only
- Request Permissions

Human Cancer Biology

Select this article
Impact of Ischemia and Procurement Conditions on Gene Expression in Renal Cell Carcinoma
- Nick W. Liu,
- Thomas Sanford,
- Ramaprasad Srinivasan,
- Jack L. Liu,
- Kiranpreet Khurana,
- Olga Aprelikova,
- Vladimir Valero,
- Charles Bechert,
- Robert Worrell,
- Peter A. Pinto,
- Youfeng Yang,
- Maria Merino,
- W. Marston Linehan,
- and Gennady Bratslavsky
Clin Cancer Res January 1, 2013 19:42-49; Published OnlineFirst November 7, 2012; doi:10.1158/1078-0432.CCR-12-2606
- Abstract
- Full Text
- Full Text (PDF)
- Figures Only
- Request Permissions
Select this article
The Severity of Neural Invasion Is Associated with Shortened Survival in Colon Cancer
- Florian Liebl,
- Ihsan Ekin Demir,
- Robert Rosenberg,
- Alexandra Boldis,
- Esra Yildiz,
- Kristina Kujundzic,
- Timo Kehl,
- Dominic Dischl,
- Tibor Schuster,
- Matthias Maak,
- Karen Becker,
- Rupert Langer,
- Melanie Laschinger,
- Helmut Friess,
- and Güralp O. Ceyhan
Clin Cancer Res January 1, 2013 19:50-61; Published OnlineFirst November 12, 2012; doi:10.1158/1078-0432.CCR-12-2392
- Abstract
- Full Text
- Full Text (PDF)
- Figures Only
- Supplementary Data
- Request Permissions
Select this article
The Critical Role of Dysregulated FOXM1–PLAUR Signaling in Human Colon Cancer Progression and Metastasis
- Dawei Li,
- Ping Wei,
- Zhihai Peng,
- Chen Huang,
- Huamei Tang,
- Zhiliang Jia,
- Jiujie Cui,
- Xiangdong Le,
- Suyun Huang,
- and Keping Xie
Clin Cancer Res January 1, 2013 19:62-72; Published OnlineFirst November 7, 2012; doi:10.1158/1078-0432.CCR-12-1588
- Abstract
- Full Text
- Full Text (PDF)
- Figures Only
- Supplementary Data
- Request Permissions
Select this article
miRNA-34b Inhibits Prostate Cancer through Demethylation, Active Chromatin Modifications, and AKT Pathways
- Shahana Majid,
- Altaf A. Dar,
- Sharanjot Saini,
- Varahram Shahryari,
- Sumit Arora,
- Mohd Saif Zaman,
- Inik Chang,
- Soichiro Yamamura,
- Yuichiro Tanaka,
- Takeshi Chiyomaru,
- Guoren Deng,
- and Rajvir Dahiya
Clin Cancer Res January 1, 2013 19:73-84; Published OnlineFirst November 12, 2012; doi:10.1158/1078-0432.CCR-12-2952
- Abstract
- Full Text
- Full Text (PDF)
- Figures Only
- Supplementary Data
- Request Permissions

Cancer Therapy: Preclinical

Select this article
Combined Administration of Rituximab and ON 013105 Induces Apoptosis in Mantle Cell Lymphoma Cells and Reduces Tumor Burden in a Mouse Model of Mantle Cell Lymphoma
- Anil Prasad,
- Ashutosh Shrivastava,
- Evangelos Papadopoulos,
- Paula M. Kuzontkoski,
- M.V. Ramana Reddy,
- Amanda M. Gillum,
- Ramesh Kumar,
- E. Premkumar Reddy,
- and Jerome E. Groopman
Clin Cancer Res January 1, 2013 19:85-95; Published OnlineFirst November 1, 2012; doi:10.1158/1078-0432.CCR-12-1425
- Abstract
- Full Text
- Full Text (PDF)
- Figures Only
- Supplementary Data
- Request Permissions
Select this article
Targeting the Phosphoinositide 3-Kinase p110-α Isoform Impairs Cell Proliferation, Survival, and Tumor Growth in Small Cell Lung Cancer
- Anna Wojtalla,
- Barbara Fischer,
- Nataliya Kotelevets,
- Francesco A. Mauri,
- Jens Sobek,
- Hubert Rehrauer,
- Carlos Wotzkow,
- Mario P. Tschan,
- Michael J. Seckl,
- Uwe Zangemeister-Wittke,
- and Alexandre Arcaro
Clin Cancer Res January 1, 2013 19:96-105; Published OnlineFirst November 21, 2012; doi:10.1158/1078-0432.CCR-12-1138
- Abstract
- Full Text
- Full Text (PDF)
- Figures Only
- Supplementary Data
- Request Permissions
Select this article
Interleukin 15 Provides Relief to CTLs from Regulatory T Cell–Mediated Inhibition: Implications for Adoptive T Cell–Based Therapies for Lymphoma
- Serena K. Perna,
- Biagio De Angelis,
- Daria Pagliara,
- Sayyeda T. Hasan,
- Lan Zhang,
- Aruna Mahendravada,
- Helen E. Heslop,
- Malcolm K. Brenner,
- Cliona M. Rooney,
- Gianpietro Dotti,
- and Barbara Savoldo
Clin Cancer Res January 1, 2013 19:106-117; Published OnlineFirst November 13, 2012; doi:10.1158/1078-0432.CCR-12-2143
- Abstract
- Full Text
- Full Text (PDF)
- Figures Only
- Supplementary Data
- Request Permissions
Select this article
Sequence Dependence of MEK Inhibitor AZD6244 Combined with Gemcitabine for the Treatment of Biliary Cancer
- Junyao Xu,
- Jennifer J. Knox,
- Emin Ibrahimov,
- Eric Chen,
- Stefano Serra,
- Ming Tsao,
- Pinjiang Cao,
- Douglass Vines,
- David E. Green,
- Cristiane Metran-Nascente,
- Mairead G. McNamara,
- and David W. Hedley
Clin Cancer Res January 1, 2013 19:118-127; Published OnlineFirst October 22, 2012; doi:10.1158/1078-0432.CCR-12-2557
- Abstract
- Full Text
- Full Text (PDF)
- Figures Only
- Supplementary Data
- Request Permissions
Select this article
Targeted Delivery of Paclitaxel to EphA2-Expressing Cancer Cells
- Si Wang,
- Roberta Noberini,
- John L. Stebbins,
- Swadesh Das,
- Ziming Zhang,
- Bainan Wu,
- Sayantan Mitra,
- Sandrine Billet,
- Ana Fernandez,
- Neil A. Bhowmick,
- Shinichi Kitada,
- Elena B. Pasquale,
- Paul B. Fisher,
- and Maurizio Pellecchia
Clin Cancer Res January 1, 2013 19:128-137; Published OnlineFirst November 15, 2012; doi:10.1158/1078-0432.CCR-12-2654
- Abstract
- Full Text
- Full Text (PDF)
- Figures Only
- Supplementary Data
- Request Permissions
Select this article
Sphingosine Kinase 1 Overexpression Contributes to Cetuximab Resistance in Human Colorectal Cancer Models
- Roberta Rosa,
- Roberta Marciano,
- Umberto Malapelle,
- Luigi Formisano,
- Lucia Nappi,
- Claudia D'Amato,
- Valentina D'Amato,
- Vincenzo Damiano,
- Gabriella Marfè,
- Silvana Del Vecchio,
- Antonella Zannetti,
- Adelaide Greco,
- Alfonso De Stefano,
- Chiara Carlomagno,
- Bianca Maria Veneziani,
- Giancarlo Troncone,
- Sabino De Placido,
- and Roberto Bianco
Clin Cancer Res January 1, 2013 19:138-147; Published OnlineFirst November 19, 2012; doi:10.1158/1078-0432.CCR-12-1050
- Abstract
- Full Text
- Full Text (PDF)
- Figures Only
- Supplementary Data
- Request Permissions
Select this article
Diphtheria Toxin–Epidermal Growth Factor Fusion Protein DAB₃₈₉EGF for the Treatment of Bladder Cancer
- Xiaoping Yang,
- Elizabeth Kessler,
- Lih-Jen Su,
- Andrew Thorburn,
- Arthur E. Frankel,
- Yuan Li,
- Francisco G. La Rosa,
- Jingping Shen,
- Chuan-Yuan Li,
- Marileila Varella-Garcia,
- L. Michael Glodé,
- and Thomas W. Flaig
Clin Cancer Res January 1, 2013 19:148-157; Published OnlineFirst November 21, 2012; doi:10.1158/1078-0432.CCR-12-1258
- Abstract
- Full Text
- Full Text (PDF)
- Figures Only
- Request Permissions
Select this article
Molecular Imaging Reveals a Role for AKT in Resistance to Cisplatin for Ovarian Endometrioid Adenocarcinoma
- Hanxiao Wang,
- Stefanie Galbán,
- Rong Wu,
- Brittany M. Bowman,
- Amanda Witte,
- Katrin Vetter,
- Craig J. Galbán,
- Brian D. Ross,
- Kathleen R. Cho,
- and Alnawaz Rehemtulla
Clin Cancer Res January 1, 2013 19:158-169; Published OnlineFirst October 24, 2012; doi:10.1158/1078-0432.CCR-12-2380
- Abstract
- Full Text
- Full Text (PDF)
- Figures Only
- Request Permissions
Select this article
Endoglin (CD105) Contributes to Platinum Resistance and Is A Target for Tumor-Specific Therapy in Epithelial Ovarian Cancer
- Angela J. Ziebarth,
- Somaira Nowsheen,
- Adam D. Steg,
- Monjri M. Shah,
- Ashwini A. Katre,
- Zachary C. Dobbin,
- Hee-Dong Han,
- Gabriel Lopez-Berestein,
- Anil K. Sood,
- Michael Conner,
- Eddy S. Yang,
- and Charles N. Landen
Clin Cancer Res January 1, 2013 19:170-182; Published OnlineFirst November 12, 2012; doi:10.1158/1078-0432.CCR-12-1045
- Abstract
- Full Text
- Full Text (PDF)
- Figures Only
- Supplementary Data
- Request Permissions

Imaging, Diagnosis, Prognosis

Select this article
Development of [¹¹C]erlotinib Positron Emission Tomography for In VivoEvaluation of EGF Receptor Mutational Status
- Idris Bahce,
- Egbert F. Smit,
- Mark Lubberink,
- Astrid A. M. van der Veldt,
- Maqsood Yaqub,
- Albert D. Windhorst,
- Robert C. Schuit,
- Erik Thunnissen,
- Daniëlle A. M. Heideman,
- Pieter E. Postmus,
- Adriaan A. Lammertsma,
- and N. Harry Hendrikse
Clin Cancer Res January 1, 2013 19:183-193; Published OnlineFirst November 7, 2012; doi:10.1158/1078-0432.CCR-12-0289
- Abstract
- Full Text
- Full Text (PDF)
- Figures Only
- Supplementary Data
Free Article
Select this article
Biomarker Discovery in Non–Small Cell Lung Cancer: Integrating Gene Expression Profiling, Meta-analysis, and Tissue Microarray Validation
- Johan Botling,
- Karolina Edlund,
- Miriam Lohr,
- Birte Hellwig,
- Lars Holmberg,
- Mats Lambe,
- Anders Berglund,
- Simon Ekman,
- Michael Bergqvist,
- Fredrik Pontén,
- André König,
- Oswaldo Fernandes,
- Mats Karlsson,
- Gisela Helenius,
- Christina Karlsson,
- Jörg Rahnenführer,
- Jan G Hengstler,
- and Patrick Micke
Clin Cancer Res January 1, 2013 19:194-204; Published OnlineFirst October 2, 2012; doi:10.1158/1078-0432.CCR-12-1139
- Abstract
- Full Text
- Full Text (PDF)
- Figures Only
- Supplementary Data
- Request Permissions

Cancer Therapy: Clinical

Select this article
Individual Patient-Specific Immunity against High-Grade Glioma after Vaccination with Autologous Tumor Derived Peptides Bound to the 96 KD Chaperone Protein
- Courtney A. Crane,
- Seunggu J. Han,
- Brian Ahn,
- Jessica Oehlke,
- Valerie Kivett,
- Anne Fedoroff,
- Nicholas Butowski,
- Susan M. Chang,
- Jennifer Clarke,
- Mitchel S. Berger,
- Michael W. McDermott,
- Michael D. Prados,
- and Andrew T. Parsa
Clin Cancer Res January 1, 2013 19:205-214; Published OnlineFirst August 7, 2012;doi:10.1158/1078-0432.CCR-11-3358
- Abstract
- Full Text
- Full Text (PDF)
- Figures Only
- Supplementary Data
- Request Permissions
Select this article
Targeted MET Inhibition in Castration-Resistant Prostate Cancer: A Randomized Phase II Study and Biomarker Analysis with Rilotumumab plus Mitoxantrone and Prednisone
- Charles J. Ryan,
- Mark Rosenthal,
- Siobhan Ng,
- Joshi Alumkal,
- Joel Picus,
- Gwenaëlle Gravis,
- Karim Fizazi,
- Frédéric Forget,
- Jean-Pascal Machiels,
- Sandy Srinivas,
- Min Zhu,
- Rui Tang,
- Kelly S. Oliner,
- Yizhou Jiang,
- Elwyn Loh,
- Sarita Dubey,
- and Winald R. Gerritsen
Clin Cancer Res January 1, 2013 19:215-224; Published OnlineFirst November 7, 2012; doi:10.1158/1078-0432.CCR-12-2605
- Abstract
- Full Text
- Full Text (PDF)
- Figures Only
- Supplementary Data
- Request Permissions
Select this article
Progression-Free Survival as a Surrogate Endpoint for Median Overall Survival in Metastatic Colorectal Cancer: Literature-Based Analysis from 50 Randomized First-Line Trials
- Clemens Giessen,
- Ruediger Paul Laubender,
- Donna Pauler Ankerst,
- Sebastian Stintzing,
- Dominik Paul Modest,
- Ulrich Mansmann,
- and Volker Heinemann
Clin Cancer Res January 1, 2013 19:225-235; Published OnlineFirst November 13, 2012; doi:10.1158/1078-0432.CCR-12-1515
- Abstract
- Full Text
- Full Text (PDF)
- Figures Only
- Supplementary Data
- Request Permissions
Select this article
Phase I and Clinical Pharmacology Study of Bevacizumab, Sorafenib, and Low-Dose Cyclophosphamide in Children and Young Adults with Refractory/Recurrent Solid Tumors
- Fariba Navid,
- Sharyn D. Baker,
- M. Beth McCarville,
- Clinton F. Stewart,
- Catherine A. Billups,
- Jianrong Wu,
- Andrew M. Davidoff,
- Sheri L. Spunt,
- Wayne L. Furman,
- Lisa M. McGregor,
- Shuiying Hu,
- John C. Panetta,
- David Turner,
- Demba Fofana,
- Wilburn E. Reddick,
- Wing Leung,
- and Victor M. Santana
Clin Cancer Res January 1, 2013 19:236-246; Published OnlineFirst November 8, 2012; doi:10.1158/1078-0432.CCR-12-1897
- Abstract
- Full Text
- Full Text (PDF)
- Figures Only
- Request Permissions
Select this article
A Novel HLA-A*0201 Restricted Peptide Derived from Cathepsin G Is an Effective Immunotherapeutic Target in Acute Myeloid Leukemia
- Mao Zhang,
- Pariya Sukhumalchandra,
- Atim A. Enyenihi,
- Lisa S. St. John,
- Sally A. Hunsucker,
- Elizabeth A. Mittendorf,
- Anna Sergeeva,
- Kathryn Ruisaard,
- Zein Al-Atrache,
- Patricia A. Ropp,
- Haroon Jakher,
- Tania Rodriguez-Cruz,
- Gregory Lizee,
- Karen Clise-Dwyer,
- Sijie Lu,
- Jeffrey J. Molldrem,
- Gary L. Glish,
- Paul M. Armistead,
- and Gheath Alatrash
Clin Cancer Res January 1, 2013 19:247-257; Published OnlineFirst November 12, 2012; doi:10.1158/1078-0432.CCR-12-2753
- Abstract
- Full Text
- Full Text (PDF)
- Figures Only
- Supplementary Data
- Request Permissions
Select this article
A Randomized Phase II Trial of Vismodegib versus Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients with Previously Untreated Metastatic Colorectal Cancer
- Jordan Berlin,
- Johanna C. Bendell,
- Lowell L. Hart,
- Irfan Firdaus,
- Ira Gore,
- Robert C. Hermann,
- Mary F. Mulcahy,
- Mark M. Zalupski,
- Howard M. Mackey,
- Robert L. Yauch,
- Richard A. Graham,
- Gordon L. Bray,
- and Jennifer A. Low
Clin Cancer Res January 1, 2013 19:258-267; Published OnlineFirst October 18, 2012; doi:10.1158/1078-0432.CCR-12-1800
- Abstract
- Full Text
- Full Text (PDF)
- Figures Only
- Supplementary Data
- Request Permissions
Select this article
A Multicenter, Phase I, Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Etirinotecan Pegol in Patients with Refractory Solid Tumors
- Gayle S. Jameson,
- John T. Hamm,
- Glen J. Weiss,
- Carlos Alemany,
- Stephen Anthony,
- Michele Basche,
- Ramesh K. Ramanathan,
- Mitesh J. Borad,
- Raoul Tibes,
- Allen Cohn,
- Ioana Hinshaw,
- Robert Jotte,
- Lee S. Rosen,
- Ute Hoch,
- Michael A. Eldon,
- Robert Medve,
- Katrina Schroeder,
- Erica White,
- and Daniel D. Von Hoff
Clin Cancer Res January 1, 2013 19:268-278; Published OnlineFirst November 7, 2012; doi:10.1158/1078-0432.CCR-12-1201
- Abstract
- Full Text
- Full Text (PDF)
- Figures Only
- Request Permissions

Predictive Biomarkers and Personalized Medicine

Select this article
An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance
- Lauren Averett Byers,
- Lixia Diao,
- Jing Wang,
- Pierre Saintigny,
- Luc Girard,
- Michael Peyton,
- Li Shen,
- Youhong Fan,
- Uma Giri,
- Praveen K. Tumula,
- Monique B. Nilsson,
- Jayanthi Gudikote,
- Hai Tran,
- Robert J.G. Cardnell,
- David J. Bearss,
- Steven L. Warner,
- Jason M. Foulks,
- Steven B. Kanner,
- Varsha Gandhi,
- Nancy Krett,
- Steven T. Rosen,
- Edward S. Kim,
- Roy S. Herbst,
- George R. Blumenschein,
- J. Jack Lee,
- Scott M. Lippman,
- K. Kian Ang,
- Gordon B. Mills,
- Waun K. Hong,
- John N. Weinstein,
- Ignacio I. Wistuba,
- Kevin R. Coombes,
- John D. Minna,
- and John V. Heymach
Clin Cancer Res January 1, 2013 19:279-290; Published OnlineFirst October 22, 2012; doi:10.1158/1078-0432.CCR-12-1558
- Abstract
- Full Text
- Full Text (PDF)
- Figures Only
- Supplementary Data
- Request Permissions
Select this article
Predictive Biomarkers of Sensitivity to the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Preclinical Breast Cancer Models
- Jennifer R. Diamond,
- S. Gail Eckhardt,
- Aik Choon Tan,
- Timothy P. Newton,
- Heather M. Selby,
- Kelsey L. Brunkow,
- Maria I. Kachaeva,
- Marileila Varella-Garcia,
- Todd M. Pitts,
- Mark R. Bray,
- Graham C. Fletcher,
- and John J. Tentler
Clin Cancer Res January 1, 2013 19:291-303; Published OnlineFirst November 7, 2012; doi:10.1158/1078-0432.CCR-12-1611
- Abstract
- Full Text
- Full Text (PDF)
- Figures Only
- Supplementary Data
- Request Permissions

Letters to the Editor

IGKC and Prognosis in Breast Cancer–Letter
- Marcus Schmidt,
- Patrick Micke,
- and Jan G. Hengstler
Clin Cancer Res January 1, 2013 19:304; Published OnlineFirst December 11, 2012;doi:10.1158/1078-0432.CCR-12-2818
- Full Text
- Full Text (PDF)
- Request Permissions
IGKC and Prognosis in Breast Cancer–Response
- Theresa L. Whiteside and
- Soldano Ferrone
Clin Cancer Res January 1, 2013 19:305; Published OnlineFirst December 11, 2012;doi:10.1158/1078-0432.CCR-12-3200
- Full Text
- Full Text (PDF)
- Request Permissions

Correction

Correction: The Impact of Non–Drug-Related Toxicities on the Estimation of the Maximum Tolerated Dose in Phase I Trials
Clin Cancer Res January 1, 2013 19:306; Published OnlineFirst November 27, 2012;doi:10.1158/1078-0432.CCR-12-3447
- Full Text
- Full Text (PDF)
- Request Permissions

Retraction

Retraction: DNA Methylation Profiles of Lymphoid and Hematopoietic Malignancies
Clin Cancer Res January 1, 2013 19:307; Published OnlineFirst December 17, 2012;doi:10.1158/1078-0432.CCR-12-3679
- Full Text
- Full Text (PDF)
- Request Permissions

期刊中心

Clinical Cancer Research (CLIN CANCER RES) 《临床癌症研究》

热点解读

全球精选全文

中国作者重要发表

最新一期

Highlights of This Issue

CCR Translations

Secrets of Drug Resistance in NSCLC Exposed by New Molecular Definition of EMT

CCR Perspectives in Drug Approval

Technology Assessment for New Oncology Drugs

Statistics in Clinical Cancer Research

Competing Risks and Multistate Models

CCR Drug Updates

Brentuximab Vedotin

Molecular Pathways

Molecular Pathways: Involvement of Immune Pathways in the Therapeutic Response and Outcome in Breast Cancer

Molecular Pathways: Targeting Mdm2 and Mdm4 in Cancer Therapy

Human Cancer Biology

Impact of Ischemia and Procurement Conditions on Gene Expression in Renal Cell Carcinoma

The Severity of Neural Invasion Is Associated with Shortened Survival in Colon Cancer

The Critical Role of Dysregulated FOXM1–PLAUR Signaling in Human Colon Cancer Progression and Metastasis

miRNA-34b Inhibits Prostate Cancer through Demethylation, Active Chromatin Modifications, and AKT Pathways

Cancer Therapy: Preclinical

Combined Administration of Rituximab and ON 013105 Induces Apoptosis in Mantle Cell Lymphoma Cells and Reduces Tumor Burden in a Mouse Model of Mantle Cell Lymphoma

Targeting the Phosphoinositide 3-Kinase p110-α Isoform Impairs Cell Proliferation, Survival, and Tumor Growth in Small Cell Lung Cancer

Interleukin 15 Provides Relief to CTLs from Regulatory T Cell–Mediated Inhibition: Implications for Adoptive T Cell–Based Therapies for Lymphoma

Sequence Dependence of MEK Inhibitor AZD6244 Combined with Gemcitabine for the Treatment of Biliary Cancer

Targeted Delivery of Paclitaxel to EphA2-Expressing Cancer Cells

Sphingosine Kinase 1 Overexpression Contributes to Cetuximab Resistance in Human Colorectal Cancer Models

Diphtheria Toxin–Epidermal Growth Factor Fusion Protein DAB389EGF for the Treatment of Bladder Cancer

Molecular Imaging Reveals a Role for AKT in Resistance to Cisplatin for Ovarian Endometrioid Adenocarcinoma

Endoglin (CD105) Contributes to Platinum Resistance and Is A Target for Tumor-Specific Therapy in Epithelial Ovarian Cancer

Imaging, Diagnosis, Prognosis

Development of [11C]erlotinib Positron Emission Tomography for In VivoEvaluation of EGF Receptor Mutational Status

Biomarker Discovery in Non–Small Cell Lung Cancer: Integrating Gene Expression Profiling, Meta-analysis, and Tissue Microarray Validation

Cancer Therapy: Clinical

Individual Patient-Specific Immunity against High-Grade Glioma after Vaccination with Autologous Tumor Derived Peptides Bound to the 96 KD Chaperone Protein

Targeted MET Inhibition in Castration-Resistant Prostate Cancer: A Randomized Phase II Study and Biomarker Analysis with Rilotumumab plus Mitoxantrone and Prednisone

Progression-Free Survival as a Surrogate Endpoint for Median Overall Survival in Metastatic Colorectal Cancer: Literature-Based Analysis from 50 Randomized First-Line Trials

Phase I and Clinical Pharmacology Study of Bevacizumab, Sorafenib, and Low-Dose Cyclophosphamide in Children and Young Adults with Refractory/Recurrent Solid Tumors

A Novel HLA-A*0201 Restricted Peptide Derived from Cathepsin G Is an Effective Immunotherapeutic Target in Acute Myeloid Leukemia

A Randomized Phase II Trial of Vismodegib versus Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients with Previously Untreated Metastatic Colorectal Cancer

A Multicenter, Phase I, Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Etirinotecan Pegol in Patients with Refractory Solid Tumors

Predictive Biomarkers and Personalized Medicine

An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

Predictive Biomarkers of Sensitivity to the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Preclinical Breast Cancer Models

Letters to the Editor

IGKC and Prognosis in Breast Cancer–Letter

IGKC and Prognosis in Breast Cancer–Response

Correction

Correction: The Impact of Non–Drug-Related Toxicities on the Estimation of the Maximum Tolerated Dose in Phase I Trials

Retraction

Retraction: DNA Methylation Profiles of Lymphoid and Hematopoietic Malignancies

过刊浏览

同类期刊影响因子排行

Clinical Cancer Research
(CLIN CANCER RES) 《临床癌症研究》

Diphtheria Toxin–Epidermal Growth Factor Fusion Protein DAB₃₈₉EGF for the Treatment of Bladder Cancer

Development of [¹¹C]erlotinib Positron Emission Tomography for In VivoEvaluation of EGF Receptor Mutational Status